Home›Stock Screener›Sai Life Sciences

Sai Life Sciences Share Price Today | Stock Price & Sai Life Sciences Share Screener

SAILIFE Pharmaceuticals & Biotechnology
Live Share Price NSE
₹1788.10
▲ 36.60 (2.09%)
2026-11-18 00:00:00
Live Share Price BSE
₹1792.25
▲ 40.75 (2.33%)
2026-11-18 00:00:00

As of November 18, 2026, the live Sai Life Sciences share price (NSE: SAILIFE) is ₹1,788.10 on NSE and ₹1,792.25 on BSE, up 2.09% from the previous close, with shares trading between ₹1,750.40 and ₹1,819.20 in today's trading session, and a 52-week range of ₹795.00–₹1,928.80. Track SAILIFE company valuation to gauge the company's total market size. Use the Sai Life Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sai Life Sciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹618 and net income of ₹104, with EBITDA of ₹192, an operating margin of 29.0% and a profit margin of 16.8%.

Sai Life Sciences Market Cap ₹37,200.85 Cr.
SAILIFE P/E Ratio (TTM) 101.70
Sai Life Sciences P/B Ratio 14.23
EPS (TTM) ₹16.43
Dividend Yield -
Debt to Equity 0.14
SAILIFE 52 Week High ₹1928.80
Sai Life Sciences 52 Week Low ₹795.00
Operating Margin 29.00%
Profit Margin 16.83%
SAILIFE Revenue (TTM) ₹618.00
EBITDA ₹192.00
Net Income ₹104.00
Total Assets ₹3,626.00
Total Equity ₹2,484.00

Sai Life Sciences Share Price Chart

Track the current stock price of Sai Life Sciences with an interactive chart. Analyse SAILIFE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sai Life Sciences stock quote in one place.

The quote of ₹1,788.10 sits between the 52-week low of ₹795.00 and the 52-week high of ₹1,928.80, and the latest session moved 2.09% from the previous close.

Sai Life Sciences Company Profile - Fundamental Screener

Screen Sai Life Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SAILIFE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE570L01029.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE570L01029

Sai Life Sciences Balance Sheet Screener

Screen SAILIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹3,626, up from ₹3,160 in 2025.

Latest statistics put total assets at ₹3,626 and shareholder funds at ₹2,484, with a leverage ratio of 0.14.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 3,626 3,160 2,275 2,187 2,157 1,817 1,410 1,216
Current Assets 0 0 0 0 0 0 0 0
Fixed Assets 1,815 1,488 1,180 1,037 751 701 641 374

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 309 299 560 540 565 356 149 160
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 2,484 2,128 975 888 879 863 794 720
Share Capital 21 21 18 18 18 18 16 16
Reserves & Surplus 2,463 2,108 957 870 861 845 777 703

Sai Life Sciences Income Statement Screener - Profit & Revenue Analysis

Screen Sai Life Sciences income statement and profit fundamentals. Analyze SAILIFE quarterly results. Sai Life Sciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹618 and net profit was ₹104, equal to earnings per unit of ₹4.93, at an operating margin of 29%.

In that period expenses were ₹426, interest cost ₹8 and tax ₹35. The next period listed, 2026-Jun, shows revenue of ₹558 and net profit of ₹73.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Dec

Revenue and Expenses

Revenue 618 558 663 589 506 553 565 443 288 406 449 395
Expenses 426 406 472 422 376 392 377 315 254 293 320 287

Operating Costs and Margins

EBITDA 192 152 190 167 131 161 188 128 34 112 129 108
Operating Profit % 29.00% 27.00% 28.00% 27.00% 24.00% 27.00% 32.00% 28.00% 9.00% 26.00% 27.00% 25.00%
Depreciation 45 46 48 38 38 40 44 31 31 36 34 31
Interest 8 8 11 11 12 9 10 21 21 21 23 23

Profit and Earnings

Profit Before Tax 139 98 131 119 81 112 134 76 -18 55 72 53
Tax 35 25 33 31 20 28 34 20 -5 14 18 13
Net Profit 104 73 98 88 61 84 100 56 -14 42 54 40
EPS 4.93 3.46 4.63 4.24 2.90 4.01 4.77 31.00 -0.74 2.22 2.89 2.19

Sai Life Sciences Cash Flow Screener - Liquidity Fundamentals

Screen SAILIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹509, and net cash flow was an outflow of ₹9.

Over the same period, investing activities used ₹395 and financing activities used ₹124.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities 509 314 263 219 105 -36 116 129
Investing Activities -395 -536 -191 -99 -102 -260 -262 -158

Financing and Net Cash

Financing Activities -124 301 -95 -201 72 296 -4 268
Net Cash Flow -9 79 -24 -80 75 -1 -150 239

Sai Life Sciences Shareholding Pattern Screener

See Sai Life Sciences shareholding pattern with promoter, FII, and DII holdings. Check Sai Life Sciences promoter holding and ownership changes for SAILIFE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 34.61%, foreign institutions 21.17%, domestic institutions 31.54% and the public 6.13%, spread across 117,527 shareholders.

The shareholder count was 117,527 in 2026-Mar, compared with 125,096 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Jul

Promoter Holding

Promoter Holding 34.61% 34.53% 34.50% 35.17% 35.15% 34.94% 34.70% 39.64%

Institutional Investors

FII Holding 21.17% 19.65% 19.91% 12.36% 14.58% 22.50% 21.40% 0.00%
DII Holding 31.54% 32.71% 32.32% 13.26% 21.64% 29.91% 31.41% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 6.13% 6.78% 7.21% 7.69% 6.56% 7.91% 5.95% 0.00%
Other Holding 6.56% 6.33% 6.05% 31.52% 22.07% 4.74% 6.54% 60.36%
Shareholder Count 117,527 125,096 143,124 140,677 126,380 119,705 114,820 70

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sai Life Sciences. Sai Life Sciences dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Sai Life Sciences.

Sai Life Sciences Stock Index Membership - Nifty & Sensex

See which indices include Sai Life Sciences stock. Check SAILIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 10 indices, including BSE INDEX BSE HC.

Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX BSEIPO, BSE INDEX SMLCAP, NIFTY 500.

Complete Index List

BSE INDEX BSE HC
BSE INDEX BSEIPO
BSE INDEX SMLCAP
NIFTY 500
NIFTY IPO
NIFTY MIDSML 400
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 MULTICAP

Sai Life Sciences Market Events Screener - Corporate Actions

Get Sai Life Sciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sai Life Sciences stock events that may affect SAILIFE share price, along with derivatives, futures and options activity and sector gainers.

10 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 5, 2026, with a record date of November 5, 2026.

It is followed by Annual General Meeting dated September 17, 2026 and Quarterly Result Announcement dated August 6, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-05 2026-11-05 Quarterly Result Announcement NA 1.32%
2026-09-17 2026-09-17 Annual General Meeting NA 5.69%
2026-08-06 2026-08-06 Quarterly Result Announcement NA 12.96%
2026-05-14 2026-05-14 Quarterly Result Announcement NA 13.13%
2026-02-05 2026-02-05 Quarterly Result Announcement NA 0.21%
2025-11-06 2025-11-06 Quarterly Result Announcement NA 3.40%
2025-09-11 2025-09-11 Annual General Meeting NA 8.86%
2025-08-07 2025-08-07 Quarterly Result Announcement NA -2.74%
2025-05-13 2025-05-13 Quarterly Result Announcement NA -0.61%
2025-02-06 2025-02-06 Quarterly Result Announcement NA -0.14%

Sai Life Sciences Competitors Screener - Peer Stocks Comparison

Screen SAILIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 448,676 40.80 61,674 12.69% 11,565 60.46
Divis Laboratories 295,997 87.70 11,067 13.95% 2,568 68.76
Torrent Pharmaceuticals 177,586 85.00 13,886 20.34% 2,138 47.23
Laurus Labs 126,325 89.90 6,868 22.01% 890 57.04
Zydus Life Science 120,119 27.60 27,658 17.64% 5,026 55.91
Dr Reddys Laboratories 115,854 41.80 35,059 3.90% 4,158 71.26
Cipla 112,131 39.50 29,045 2.24% 3,870 53.06
Mankind Pharma 107,805 47.90 14,636 14.85% 1,938 61.37
Aurobindo Pharma 103,229 25.80 34,145 5.56% 3,503 60.39
Lupin 89,172 17.30 29,039 26.75% 5,356 39.39

Sai Life Sciences Company Announcements - News & Reports Screener

Screen SAILIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 14, 2026.

The next most recent announcements are dated November 13, 2026 and November 13, 2026.

Date Update Actions
2026-11-14 Announcement under Regulation 30 (LODR)-Credit Rating -
2026-11-13 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-11-13 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-11-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-06 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-06 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-06 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-05 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-11-05 Announcement under Regulation 30 (LODR)-Change in Management -
2026-11-05 Unaudited Financial Results For The Second Quarter And Half Year Ended 30Th September 2026 -
2026-11-05 Board Meeting Outcome for Outcome Of The Board Meeting Held On 05Th November 2026. -
2026-10-19 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-12 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-10-05 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Board Meeting Intimation for Unaudited Financial Results Of Q-2 (FY 2026-27) -
2026-09-28 Closure of Trading Window -
2026-09-18 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-09-17 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-17 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-04 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1,788.10, within a 52-week range of ₹795.00 to ₹1,928.80. The P/E ratio is 101.70 and the P/B ratio is 14.23, with earnings per unit of ₹16.43. Market capitalisation stands at ₹37,200.85 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 18, 2026. This page covers 8 balance sheet periods, 12 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.